Lucrezia Laterza
Overview
Explore the profile of Lucrezia Laterza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
433
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lenti M, Hammer H, Tacheci I, Burgos R, Schneider S, Foteini A, et al.
United European Gastroenterol J
. 2025 Mar;
PMID: 40088199
Malabsorption is a complex and multifaceted condition characterised by the defective passage of nutrients into the blood and lymphatic streams. Several congenital or acquired disorders may cause either selective or...
2.
Ribaudi E, Amato S, Becherucci G, Carillo S, Covello C, Mora V, et al.
Nutrients
. 2025 Mar;
17(5).
PMID: 40077704
This scoping review aims to map the existing literature on nutritional knowledge among people with IBD, identify gaps in current understanding, and provide guidance for future educational interventions. : Inflammatory...
3.
Puca P, Del Gaudio A, Iaccarino J, Blasi V, Coppola G, Laterza L, et al.
Cancers (Basel)
. 2025 Mar;
17(5).
PMID: 40075582
The advent of Janus kinase (JAK) inhibitors, including tofacitinib, filgotinib, and upadacitinib, has significantly widened the therapeutic options for patients with inflammatory bowel disease (IBD). These agents offer the advantage...
4.
Privitera G, Monastero L, Melita E, Schiavoni E, Napolitano D, Barini A, et al.
Dig Liver Dis
. 2025 Mar;
PMID: 40023750
Background: Data on nonmedical switching from one anti-Tumor Necrosis Factor (TNF)-α biosimilar to another in inflammatory bowel disease (IBD) are relatively sparse. We aimed to study the effects of nonmedical...
5.
Papa A, Laterza L, Papa V, Lopetuso L, Colantuono S, Coppola G, et al.
Dig Liver Dis
. 2025 Feb;
PMID: 39933974
Objectives: Atherosclerotic cardiovascular disease (ASCVD) and venous thromboembolism (VTE) are severe complications of inflammatory bowel disease (IBD). Risk factors for ASCVD and VTE in IBD are not entirely elucidated. This...
6.
Lopetuso L, Deleu S, Puca P, Abreu M, Armuzzi A, Barbara G, et al.
Inflamm Bowel Dis
. 2025 Feb;
PMID: 39932857
Background: Fecal microbiota transplantation (FMT) is emerging as a potential treatment modality for individuals living with inflammatory bowel disease (IBD). Despite its promise, the effectiveness of FMT for treating IBD,...
7.
Minordi L, Sacchetti F, Balzano D, Maresca R, DAngelo F, Larosa L, et al.
J Clin Med
. 2024 Nov;
13(22).
PMID: 39597812
This study investigated the radiological, clinical, and surgical factors linked to the risk of endoscopic recurrence following ileocolic resection for Crohn's disease. We conducted a retrospective analysis of data from...
8.
Cammarota G, Laterza L, Bibbo S, Fusco W, Rozera T, Di Brino E, et al.
Aliment Pharmacol Ther
. 2024 Nov;
61(1):65-74.
PMID: 39552383
Background: The worldwide prevalence of inflammatory bowel disease (IBD) is increasing, with its potential evolution as a global disease and a consequent increase in its burden on healthcare systems. These...
9.
Turchini L, Amatucci V, Scaldaferri F, Laterza L
J Gastrointestin Liver Dis
. 2024 Sep;
33(3):299-301.
PMID: 39348573
No abstract available.
10.
Minordi L, DAngelo F, Privitera G, Papa A, Larosa L, Laterza L, et al.
J Clin Med
. 2024 Jul;
13(14).
PMID: 39064186
Crohn's disease (CD) is a chronic, progressive inflammatory condition, involving primarily the bowel, characterized by a typical remitting-relapsing pattern. Despite endoscopy representing the reference standard for the diagnosis and assessment...